MEDEIA THERAPEUTICS LTD has a total of 36 patent applications. Its first patent ever was published in 2005. It filed its patents most often in WIPO (World Intellectual Property Organization), Argentina and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are LAFON LABOR, PROTEOTECH INC and ARRHENIUS THOMAS.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 6 | |
#2 | Argentina | 5 | |
#3 | Taiwan | 5 | |
#4 | Brazil | 2 | |
#5 | Canada | 2 | |
#6 | China | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Mexico | 2 | |
#9 | Singapore | 2 | |
#10 | United States | 2 | |
#11 | EAPO (Eurasian Patent Organization) | 1 | |
#12 | EPO (European Patent Office) | 1 | |
#13 | Finland | 1 | |
#14 | Hong Kong | 1 | |
#15 | New Zealand | 1 | |
#16 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Koistinaho Milla | 25 |
#2 | Ratilainen Jari | 25 |
#3 | Muona Anu | 21 |
#4 | Goldsteins Gundars | 4 |
#5 | Jari Ratilainen | 3 |
#6 | Anu Muona | 3 |
#7 | Milla Koistinaho | 3 |
#8 | Koistinaho Jari | 3 |
#9 | Bhor Santosh Sopan | 2 |
#10 | Pystynen Jarmo | 1 |
Publication | Filing date | Title |
---|---|---|
TW201536795A | Use of arylthiazine compounds as cytoprotectants | |
TW201441203A | N-substituted 4-aminophenols and corresponding quinone imines | |
KR20140117531A | Novel heteroarylamide derivatives having antiandrogenic properties | |
WO2013104829A1 | Novel arylamide derivatives having antiandrogenic properties | |
TW201332953A | Novel arylamide derivatives having antiandrogenic properties | |
TW201208669A | Novel arylamide derivatives having antiandrogenic properties | |
EP1773985A1 | Method for stimulating mammalian cells and mammalian cell |